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Background: DNA methylation directs the epigenetic silencing of selected regions of DNA, including the
regulation of pseudogenes, and is widespread throughout the genome. Pseudogenes are decayed copies of
duplicated genes that have spread throughout the genome by transposition. Pseudogenes are transcriptionally
silenced by DNA methylation, but little is known about how pseudogenes are targeted for methylation or how
methylation levels are maintained in different tissues.
Results: We employed bisulfite next generation sequencing to examine the methylation status of the LIN28 gene
and four processed pseudogenes derived from LIN28. The objective was to determine whether LIN28 pseudogenes
maintain the same pattern of methylation as the parental gene or acquire a methylation pattern independent of
the gene of origin. In this study, we determined that the methylation status of LIN28 pseudogenes does not
resemble the pattern evident for the LIN28 gene, but rather these pseudogenes appear to acquire methylation
patterns independent of the parental gene. Furthermore, we observed that methylation levels of the examined
pseudogenes correlate to the location of insertion within the genome. LIN28 pseudogenes inserted into gene
bodies were highly methylated in all tissues examined. In contrast, pseudogenes inserted into genomic regions that
are not proximal to genes were differentially methylated in various tissue types.
Conclusions: Our analysis suggests that Lin28 pseudogenes do not aquire patterns of tissue-specific methylation as
for the parental gene, but rather are methylated in patterns specific to the local genomic environment into which
they were inserted.
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DNA methylation controls diverse aspects of genome
regulation and transcriptional activity. Methylation of
mammalian DNA involves the addition of a methyl group
to the 5’-carbon of the cytosine in a cytosine-guanine
(CpG) dinucleotide. This system of methylation likely
evolved from a genomic defense system responsible for
preventing the spread of parasitic genetic elements. DNA
methylation has since evolved to play an active role in
maintaining genetic structure and genome regulation [1].
Methylation is involved in X-chromosome inactivation
[2,3], silencing of transposable elements [4-7], tissue-
specific gene expression [8-11], and gene imprinting
[12-15]. DNA methylation is widespread throughout the
genome, and the maintenance of methylation patterns is* Correspondence: abby.benninghoff@usu.edu; ken.white@usu.edu
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unless otherwise stated.highly regulated and tissue-specific [16,17]. DNA methyl-
transferases (DNMTs) are responsible for de novo and
maintenance methylation of the genome [18-20]. The
proper establishment and maintenance of methylation pat-
terns is critical for early development and the absence of
DNA methylation results in embryonic lethality [21-23].
DNA methylation also regulates pseudogenes within the
genome [16,24]. Pseudogenes are decayed copies of active
genes that have arisen from either a duplication event, in
which the entire gene or portion of a gene is duplicated
(non-processed pseudogenes), or from the retrotransposi-
tion of an RNA transcript into the genome (processed
pseudogenes). An analysis of the human genome estimates
that as many as 19,000 pseudogenes are evenly distributed
throughout the genome, and approximately 70% of these
are processed pseudogenes [20,25]. Ten percent of genes
within the human genome have at least one correspond-
ing pseudogene [20,26], and pseudogenes primarily arise
from parental genes that are transcriptionally active within
the germ line.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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element movement likely induces DNA methylation on
pseudogenes. Methylation of pseudogenes is elevated in
embryos, likely as a mechanism for preventing the spread
of transposable elements during embryogenesis [16,27]. In
plants, the inactivation of methyltransferases resulted in
the widespread activation of transposable elements and
pseudogenes [27], demonstrating that DNA methylation is
sufficient to prevent the activation of pseudogenes. In
humans, pseudogenes are highly methylated, presumably
to prevent transcription and further transposition [16].
Characterizing methylation patterns of pseudogenes is
critical, as pseudogenes with high sequence identity to
parental genes can lead to misinterpretation of results
in methylation studies [28,29]. The characterization of
pseudogene methylation signatures also reveals how
DNA segments are regulated by methylation networks
once inserted into the genome. In order to better under-
stand how methylation patterns are established and
maintained on pseudogenes, we examined the methyla-
tion status of four pseudogenes derived from the trans-
lational enhancer LIN28. This gene is important in early
embryo development and can also act as a reprogram-
ming factor in the production of induced pluripotent
stem cells [30,31].
LIN28 has given rise to at least ten processed pseudo-
genes within the bovine genome that vary in length be-
tween 100 to 4000 bp (Btau_4.6.1, released Nov 2, 2011).
The protein-coding region of LIN28 contains a high con-
centration of CpG sites, making the gene a potential target
for DNA methylation once inserted elsewhere in the gen-
ome as a pseudogene. By measuring the methylation levels
of selected pseudogenes and the LIN28 gene, we sought to
determine whether the same regulatory mechanism that di-
rects and maintains methylation of the LIN28 gene also
controls the methylation status of LIN28 pseudogenes.
Additionally we examined the expression of genes near the
insertion site to determine whether pseudogene methyla-
tion is involved in transcriptional control of adjacent genes.
This study is the first to characterize the methylation status
of LIN28 and its associated pseudogenes, and is the first
such research to characterize the methylation status of a
pseudogene family within the bovine genome.
Results
We assessed the methylation status of four LIN28 proc-
essed pseudogenes in six bovine tissue samples, including
brain, liver, testes, fibroblast cells, IVF blastocyst stage em-
bryo, and oocyte. Three of the LIN28 pseudogenes contain
the entire protein-coding sequence as well as a long region
downstream from the stop codon. A fourth pseudogene
contains only the terminal portion of the protein-coding re-
gion and downstream transcript (Figure 1; Additional file 1:
Figures S1-S4). These pseudogenes are likely the productsof retrotransposition of the LIN28 transcript following
RNA splicing. These four pseudogenes were selected for
examination based on their retention of the protein-coding
region, as well as insertion location and number of CpG
sites. The pseudogenes examined were as follows: LIN28P-
Ch:3 [GenBank:LOC784466] inserted into chromosome 3
approximately 20Kbp upstream of the UBQLN4 gene (84%
identity with LIN28), LIN28P-Ch:7 [GenBank:LOC781442]
on chromosome 7 inserted into the fourth intron of the
MAN2A1 gene (97% identity with LIN28), LIN28P-Ch:26
[GenBank:LOC539705] on chromosome 26 inserted within
the first intron of ACADSB (97% identity with LIN28), and
LIN28P-Ch28 [GenBank:LOC785075] on chromosome 28
has no proximity to any gene (90% identity with the LIN28
gene) (Figure 2). Primer sets were designed to profile each
individual pseudogene for a sequence within the protein-
coding region. We selected a region that offered the greatest
degree of overlap between the LIN28 gene and associated
pseudogenes. However, due to the high sequence identity
between the pseudogenes and the parental gene, the overlap
of examined CpG sites was limited by our ability to specific-
ally amplify each individual pseudogene. The available sites
in the LIN28 gene were restricted to just seven sites that
were proximal to the overlapped regions within the
pseudogenes. Pseudogenes LIN28P-Ch:3, LIN28P-Ch:7
and LIN28P-Ch:26 all contain considerable overlap be-
tween identical CpG sites. LIN28P-Ch:26 contains over-
lap of only two CpG sites with the LIN28 gene. The
LIN28 gene also shares only three overlapping CpG sites
with LIN28P-Ch:28. Because of the restricted overlap of
CpG specific sites and limited number of LIN28 CpG
sites, our assessment regarding differences between in-
dividual CpG dinucleotides among the four pseudo-
genes was limited. Rather we focused our analysis to
consider patterns of methylation among the amplified
regions from each pseudogene as a whole (Figure 3;
Additional file 1: Figures S5-S9).
Methylation status of the LIN28 family
Our results indicate that LIN28 and all examined pseudo-
genes were methylated in all bovine cell and tissue types ex-
amined. Due to the sequence similarity between LIN28 and
its derived pseudogenes we were only able to obtain cover-
age of seven CpG dinucleotides within the LIN28 gene.
This region was selected because of primer-specific amplifi-
cation adjacent to the region examined in the pseudogenes.
These dinucleotides are located in the third exon of LIN28.
All of the CpG sites were methylated in each tissue to vary-
ing degrees (Figure 3; Additional file 1: Figures S5-S9). In
addition, all pseudogenes examined were methylated in all
tissue samples. However, each pseudogene demonstrated a
distinct methylation pattern that differed sharply from the
LIN28 gene, and that correlates with the pseudogene inser-
tion location.
Figure 1 The nine processed pseudogenes of LIN28 aligned to the LIN28 processed transcript. The horizontal filled in lines represent each
pseudogene with the location relative to the start of the LIN28 protein-coding region indicated at the bottom and measured in base pairs. Vertical
lines represents start and stop codons. Sequence identity of each pseudogene to the LIN28 parental transcript is indicated on the right column
and the chromosome of insertion is indicated on the left. The dashed box shows the pseudogenes examined for methylation analysis, and the
red box indicates the location of CpG sites measured for this study.
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were inserted into a location isolated from any gene, and
both of these pseudogenes share a similar overall pattern
of methylation (Figure 3B, E; Additional file 1: Figures
S6, S9). We analyzed methylation at nine CpG dinucleo-
tides within LIN28P-Ch:3 and eight CpG dinucleotides
in LIN28P-Ch:28. In both pseudogenes, oocytes had the
lowest levels of overall methylation and blastocysts had
the highest level of methylation. The methylation pat-
terns of both pseudogenes apparently deviated from pat-
terns observed in the LIN28 gene. Within the LIN28
gene, oocytes had the highest frequency of methylation.
Alternatively, the methylation of the parental gene wasFigure 2 Location of LIN28 pseudogenes on each chromosome. Genes are re
on the chromosome are indicated by the black boxes. White arrows indicate
of each pseudogene relative to local genes. See Additional file 1: Figures S1-S
pseudogene to LIN28 and the location of all CpG sites examined.lowest in blastocyst embryos. In LIN28P-Ch:28 we ob-
served three overlapping CpG dinucleotides with the
LIN28 gene. Although limited, within these three over-
lapping sites, the inverse pattern of methylation between
the LIN28 gene and pseudogenes LIN28P-Ch:3 and
LIN28P-Ch:28 is maintained.
In contrast to the tissue-specific methylation patterns,
pseudogenes LIN28P-Ch:7 and LIN28P-Ch:26 both
are highly methylated (Figure 3C-D; Additional file 1:
Figures S7-S8). Both LIN28P-Ch:7 and LIN28P-Ch:26
were inserted into gene introns. LIN28P-Ch:7 is inserted
into the fourth intron of the gene MAN2A1. A majority
of the 27 CpG sites inspected within this pseudogenepresented by gray boxes, while the locations of pseudogene insertion
direction of gene transcription, and dashed arrows indicate the distance
4 for graphical representation of the sequence alignments of each
Figure 3 Heat map of LIN28 and LIN28 pseudogene methylation profile. Methylation profiles for LIN28 (A) and pseudogenes, LIN28P-CH:3 (B), LIN28P-
Ch:7 (C), LIN28P:26 (D), and LIN28P-CH:28 (E), are shown for the examined tissues: testes, liver, brain, fibroblast, IVF blastocyst embryos, and oocytes. The
total number of sequencing reads is indicated next to each sample. The average percentage methylation of CpG sites within the entire amplicon is
shown for each pseudogene. Each heat map cell indicates the percentage of CpG sites positive for methylation. Yellow indicates high methylation and
blue low methylation. Each CpG site corresponds to a number indicated above each sample that indicates the placement of each CpG site in relation
to the protein-coding region. CpG sites of pseudogenes that do not correspond to a CpG location within the LIN28 parental gene are represented by
‘n’. See Additional file 1: Figures S1-S4 for placing these CpG sites in sequence context for each of the pseudogenes. See Additional file 1: Figures S5-S9
for heat map representations of methylation for all sequence reads across samples for each pseudogene.
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file 1: Figure S7). The LIN28P-Ch:26 pseudogene lies within
the first intron of the gene ACADSB and is 20 kbp from
the gene IKZF5. Similar to LIN28P-Ch:7, all 26 CpG sites
examined for the LIN28P-Ch:26 pseudogene were highly
methylated at a high frequency (Figure 3D; Additional
file 1: Figure S8). The high levels of methylation observed
in both of these pseudogenes is in sharp contrast to the
moderate levels of methylation of the LIN28 gene and pseu-
dogenes not inserted into gene bodies, none of which are
as highly methylated for all tissue samples.
These apparent differences in methylation correlate to the
location of insertion of the pseudogene. LIN28 pseudogenes
inserted into gene bodies were highly methylated. Alterna-
tively, LIN28 pseudogenes with an insertion location distant
from a gene varied in the pattern of methylation in a tissue-
specific manner, although these tissue-specific patterns wereinverse with respect to the LIN28 gene (Figure 3; Additional
file 1: Figures S5-S9).
Non-CpG methylation
We observed two cytosine nucleotides that were not
contained within CpG dinucleotides that were methyl-
ated to some degree in all tissues examined. Both cyto-
sine nucleotides were located within LIN28P-Ch:7. Both
non-CpG methylation sites were located within close
proximity to CpG sites. One non-CpG methylated cyto-
sine was located between CpG sites three and four
(CGCCG) on LIN28P-Ch:7. The percentage of sequences
that were methylated at this location in the tissues ex-
amined were: 9% in testes, 13% in liver, 20% in brain,
46% in fibroblast, 46% in IVF blastocyst, and 4% in oo-
cyte. Both CpG sites flanking the specified cytosine are
highly methylated in all samples (Figure 3C; Additional
Figure 4 End-point RT-PCR. Expression of genes LIN28, ACADSB,
MAN2A1, DHDDS, IKZF5 and ACTB in the testes, liver, brain, fibroblast,
IVF blastocyst embryos and oocytes.
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sine observed is upstream from CpG site 13 in LIN28P-
Ch:7 (CCG). The percentage of methylated sequences at
this cytosine were observed to be: 8% in testes, 10% in
liver, 16% in brain, 38% in fibroblast, 40% in IVF blasto-
cyst, and 100% in oocyte. Methylation of CpG site 13 on
LIN28P-Ch:7 is high in all tissue samples (Figure 3C;
Additional file 1: Figure S7). Additionally, the methyla-
tion status of either non-CpG cytosine nucleotides is in-
dependent of the other.
Single CpG demethylation
LIN28P-Ch:26 contains a single CpG dinucleotide that is
characterized by a low frequency of methylation in a tissue-
specific manner. This CpG dinucleotide is under-methylated
in a tissue-specific manner at CpG site 16 in IVF blastocyst
and oocyte samples (Figure 3D; Additional file 1: Figure S8).
Both samples are also under-methylated relative to adjacent
CpG sites with a 13% methylation frequency in IVF blasto-
cyst and 5% frequency in oocytes, yet highly methylated for
other tissue types.
Expression of genes adjacent to LIN28 pseudogenes
End-point RT-PCR was performed to determine gene
expression of LIN28 as well as genes closely adjacent
to the four LIN28 pseudogenes in order to establish
whether methylation of pseudogenes correlated with
differences in gene expression. Expression of the genes
DHDDS, MAN2A1, ACADSB, and IKZF5 were mea-
sured in testes, liver, brain, fibroblast, IVF blastocyst,
and oocyte samples (Figure 4). Gene expression of all
genes examined did not correspond to methylation
patterns of adjacent pseudogenes (Figures 3 and 4;
Additional file 1: Figures S5-S9). IKZF5 is proximal to
LIN28P-Ch:26, which does contain a tissue-specific
methylation pattern of a single CpG site. Interestingly,
the expression pattern for IKZF5 mirrors the pattern of
methylation for LIN28P-Ch:26 in that this gene is not
expressed in oocytes or blastocyst embryos (correspond-
ing to samples with low methylation at site 16), but is
highly expressed in other tissue types (corresponding to
samples with high methylation at site 16) (Figures 3 and
4; Additional file 1: Figures S5-S9).
Discussion
The objective of our study was to determine whether the
methylation of pseudogenes followed the same patterns
as the functional parental gene by examining LIN28 as a
case study. An observation that the LIN28 pseudogenes
maintained an identical or highly similar methylation
pattern as the LIN28 gene would indicate that regulation
of LIN28 methylation is intrinsic to the gene sequence
and that methylation of pseudogenes with high sequence
identity is likely controlled by the same mechanism(s)that maintain methylation of the LIN28 gene. Alterna-
tively, an observation that pseudogene methylation pat-
terns deviated from the parental gene would indicate
that pseudogenes are subject to local regulation of
methylation patterns. In this study, we observed that
LIN28 pseudogenes do not recapitulate the same methy-
lation status as LIN28, but rather appear to acquire
methylation patterns independent of the parental gene.
Furthermore, we observed that methylation levels of the
examined pseudogenes correlate to the location of inser-
tion. To our knowledge, this study is the first to
characterize the methylation signatures of the LIN28
pseudogene family and to identify an effect of genome
location on pseudogene methylation. Previous studies
have shown that methylation patterns of pseudogenes
deviate from those of the parental gene, and our findings
are consistent with these observations [16,27,29,32].
Our examination of an entire pseudogene family high-
lights the diversity of methylation patterns apparent for
highly similar sequences. LIN28 pseudogenes inserted into
gene bodies were highly methylated in all tissues examined.
In contrast, pseudogenes inserted into genomic regions that
are not proximal to genes had reduced overall methylation
and were differentially methylated in unique tissue types.
The measurement of methylation patterns in six distinct
tissue types showed that methylation of pseudogenes can
be highly variable in different tissues (Figure 3; Additional
file 1: Figures S5-S9) and suggested that methylation of
CpG sites may be differentially regulated in these tissues.
Davis et al. BMC Genomics  (2015) 16:287 Page 6 of 10Pseudogenes not associated with genes had less methylation
in tissue samples that were highly methylated in the paren-
tal gene.
We measured methylation of seven CpG dinucleotides
located within the third exon of the LIN28 gene. Methyla-
tion of CpG dinucleotides within the gene body is generally
associated with transcriptionally active genes [25,26]. This
pattern is in contrast to methylation of the 5’ upstream and
promoter regions of genes, which are typically associated
with transcriptional silencing. Methylation of these seven
CpG dinucleotides was dependent upon tissue type. Not-
ably, oocytes had the highest levels of methylation within
the LIN28 gene. Oocytes generally maintain low levels of
global methylation relative to somatic cells [33,34]. Follow-
ing fertilization, global methylation levels decline further
and are then reestablished during embryonic and somatic
cell development [35-38]. The methylation level observed
in the LIN28 gene is counter to this pattern. However,
methylation levels measured in the LIN28P-Ch:3 and
LIN28P-Ch:28 pseudogenes are consistent with changes in
methylation levels on a global level. Within both these
pseudogenes, oocytes maintained low levels of methylation,
whereas somatic cells maintained high levels of methyla-
tion. It is possible that the methylation patterns observed
for LIN28P-Ch:3 and LIN28P-Ch:28 are maintained by the
same mechanism that maintains global levels of methyla-
tion, while methylation of the LIN28 gene is maintained by
a separate mechanism.
We also observed that methylation of pseudogenes de-
pends on the genomic context into which the pseudogene
was inserted. Both pseudogenes inserted into the intron of
a gene, LIN28P-Ch:7 and LIN28P-Ch:26, were highly meth-
ylated in all tissues. The absence of variability among tis-
sues is revealing, as insertion of a pseudogene into a gene
body appears to induce high levels of methylation. On the
other hand, both pseudogenes not associated with a gene,
LIN28P-Ch:3 and LIN28P-Ch:28, vary in the pattern of
methylation within different tissue samples, but tissue
methylation levels were similar between the two pseudo-
genes. The similarity of methylation levels among all tissue
types between similar pseudogenes indicates that pseudo-
genes share a common regulatory mechanism that estab-
lishes and maintains the methylation signature. When
considering the location of the LIN28 pseudogenes in
context of chromosomal structure, we originally postulated
that LIN28P-Ch:7 and LIN28P-Ch:26 exist in a region that
is likely euchromatin, as both pseudogenes were inserted
into gene bodies (Figure 2). Furthermore, expression data
obtained for MAN2A1 and IKZF5 (Figure 4) suggest that
these regions are transcriptionally active, providing evi-
dence that the region maintains euchromatin structure in
the tissues examined. Because LIN28P-Ch:3 and LIN28P-
Ch:28 are isolated from any local gene, it is reasonable to
expect that the local sequence environment for these genesis heterochromatin in structure. However, our expression
analysis did not directly test this hypothesis, since these two
pseudogenes do not lie within a gene body.
Other researchers have shown that a limited number of
pseudogenes have evolved to play a regulatory function
within the genome [39-44]. It is possible that the introduc-
tion of a pseudogene within a the promoter of a gene may
provide a CpG-rich sequence that can be utilized as a site
for gene silencing via DNA methylation, although this ob-
servation was not evident in our study. As indicated by the
results of our analysis of LIN28, these pseudogenes may
undergo tissue-specific methylation unique to the region of
pseudogene insertion, which lead us to investigate the rela-
tionship between methylated pseudogenes and expression
of adjacent genes. However, evidence from PCR analysis of
genes associated with the four pseudogenes, including
DHDDS, MAN2A1, ACADSB, and IKZF5, suggested that
LIN28 pseudogene methylation status was not correlated
with decreased gene expression. This observation suggests
that in the case of the LIN28 pseudogene family, methyla-
tion status of the pseudogene does not play a major role in
regulation of expression of the local genes. However,
methylation of a single CpG dinucleotide in the LIN28
pseudogene was correlated with gene expression changes
for the gene IKZF5. The LIN28P-Ch:26 pseudogene is lo-
cated within the first intron of ACADSB and 20 Kbp up-
stream from IKZF5. Within the LIN28P-Ch:26 pseudogene,
a single CpG dinucleotide at site 16 is hypomethylated in
the oocyte and blastocyst samples, a sharp contrast to the
hypermethylated status of all surrounding CpG dinucleo-
tides as well as the same CpG site in the four remaining
tissues. Interestingly, IKZF5 was not expressed in either oo-
cytes or blastocyst embryos. Although the expression pat-
tern of IKZF5 was correlated with the tissue-specific
methylation patterns observed for the pseudogene, it is
doubtful that this single CpG site is involved in the tran-
scriptional regulation of IKZF5.
Within LIN28P-Ch:7, we identified two cytosine nucleo-
tides that are methylated outside of the CpG dinucleotide
context. In both cases, the methylation has occurred on a
cytosine immediately upstream from a CpG dinucleotide.
Non-CpG methylation has been observed to occur with
higher frequency in non-dividing cells and gametes, al-
though its function remains unknown [45]. Interestingly,
the same cytosine nucleotides are observed within the
LIN28P-Ch:26 and are unmethylated in all samples. This
observation further suggests that upon integration into
the genome, methylation of the LIN28 pseudogene family
is location specific and the methylation occurs independ-
ent of their sequence.
Conclusions
In conclusion, the four LIN28 pseudogenes examined in
this study maintained methylation patterns that deviate
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another according to the genomic location into which the
pseudogene was inserted. To our knowledge, this is a
unique phenomena identified in our study, and examin-
ation of more pseudogene families will be required to deter-
mine whether the same observation is consistent for other
integrated pseudogenes. Pseudogenes derived from LIN28
have undergone mutations and no longer maintain an exact
sequence identity to the LIN28 gene. Sequence identity
ranges from 84% to 97% (Figure 1), and it is possible that
the differences in methylation pattern are a result of
changes in the pseudogene sequence. Additionally, our con-
clusions are based on methylation of CpG sites within the
pseudogenes only, as well as a limited number of CpG sites
within the LIN28 gene. Analysis of CpG dinucleotides
throughout the LIN28 parent gene as well as CpG dinucle-
otides flanking the pseudogene point on insertion would
further add to our findings. Future work should focus on
these CpG sites and would further help determine how
DNA methylation is targeted to specific genomic regions.
Although methylation status of the LIN28 pseudogenes was
not associated with changes gene expression of proximal
genes, this observation does not rule out the possibility that
CpG-rich pseudogenes could serve as sites for regulation of
gene expression by methylation, a hypothesis that may also
be addressed by survey of other pseudogene families. New
knowledge on the regulation of pseudogenes via DNA
methylation could contribute to greater understanding of
the maintenance of global and/or regional patterns of
methylation. Future work on this topic should focus on
characterizing methylation patterns for other pseudogene
families to determine whether all pseudogenes are main-
tained in a similar manner or whether sequence specific
patterns can be identified through analysis of pseudogenes.
Methods
Fibroblast cell culture
Bovine fibroblasts isolated from skin were cultured in
DMEM F12 (Thermo Scientific HyClone Laboratories, Lo-
gan, UT) supplemented with 15% fetal bovine serum (FBS)
(Thermo Scientific HyClone Laboratories), 100 U/ml peni-
cillin, and 100 mg/ml streptomycin. Cells were cultured at
37°C with 5% CO2. For cell collection fibroblasts were
treated with 0.25% trypsin prior to collection for RNA and
DNA isolation.
Oocyte maturation
The Utah State University Institutional Animal Care and
Use Committee approved all procedures for the use of ani-
mals in this study (protocol #1506). Bovine ovaries were
collected at a local abattoir (E.A. Miller, Hyrum, UT) and
used for collecting oocytes. Oocytes with 3 to 8 mm folli-
cles were aspirated along with cumulus complexes. Follow-
ing aspiration, cumulus oocyte complexes were cultured at37°C with 5% CO2 for 18 to 22 hr in TCM 199 maturation
medium containing 10% FBS (Thermo Scientific HyClone
Laboratories), 0.05 mg/ml follicle stimulating hormone,
5 mg/ml luteinizing hormone, 100 U/ml penicillin, and
100 mg/ml streptomycin.
In vitro fertilization
Following 18 to 22 hr of oocyte maturation, cryopre-
served bovine semen (Hoffman AI, Logan, UT) was
thawed in a 37°C water bath. Live sperm were isolated
by centrifugation through a 45%/90% Percoll® gradient.
Sperm were suspended in Tyrode’s albumin lactate pyru-
vate (TALP) and used for oocyte fertilization. Twenty-
four hr post fertilization, cumulus cells were removed by
vortexing the cumulus oocyte complex in phosphate
buffered saline (PBS) containing 0.32 mM sodium pyru-
vate, 5.55 mM glucose, 3 mg/ml BSA, and 10 mg/ml hy-
aluronidase. Oocytes were washed through six drops of
PBS and placed in co-culture dishes plated with cultured
cumulus cells and cultured in CR2 medium.
Tissue collection and RNA isolation
Twenty-five pooled blastocyst embryos were collected after
8 days of culture in CR2 medium, snap frozen with liquid
nitrogen, and stored at -80°C. Twenty-five pooled oocytes
were collected after 22 hr of maturation, vortexed for 5 min
in PBS to remove cumulus cells, snap frozen with liquid ni-
trogen, and stored at -80°C. RNA was isolated from oocyte
and blastocyst embryo samples using the RNeasy Mini Kit
(Qiagen, Germantown, MD) following manufacturer’s in-
structions. Bovine brain, liver, testes tissue samples were
collected immediately after slaughter and suspended in
RNALater (Ambion, Austin, TX). Samples were stored
overnight at 4°C. Fibroblasts were collected as described
above. RNA was isolated from brain, liver, testes, and fibro-
blasts using TRIzol reagent (Life Technologies, Carlsbad,
CA). Tissue samples were homogenized in 3 ml TRIzol
with a tissue homogenizer. Cells were incubated for 5 min
at room temperature, combined with 0.6 ml chloroform,
and mixed by inversion. Samples were centrifuged at
12,000 × g for 15 min at 4°C, the upper aqueous phase was
removed and combined with 1.5 ml isopropyl alcohol, then
centrifuged at 12,000 × g for 10 min at 4°C. Supernatant
was removed and the RNA was washed with 75% ethanol
and centrifuged again, then dried and resuspended in H2O.
Isolated RNA was immediately converted to cDNA using
the Superscript III Reverse Transcriptase Kit (Life Tech-
nologies) following manufacturer’s protocol. Samples were
stored at -20°C until use.
DNA isolation and bisulfite conversion
Twenty-five pooled oocytes and blastocyst embryos were
snap frozen with liquid nitrogen and stored at -80°C
until direct bisulfite conversion. DNA from brain, liver,
Table 2 Primers for end-point RT-PCR
MAN2A1 Forward GACCCATTTGGACATTCACC
Reverse TTTAGGATCAGGCCCACAAG
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phase of the TRIzol treatment used for RNA collection. The
collected interphase was combined with 0.9 ml ethanol,
mixed by inversion, and centrifuged at 2000 × g for 5 min at
4°C. The pellet was suspended with 75% ethanol and washed
by centrifugation three times. The DNA pellet was resus-
pended in 0.1 μM sodium citrate. The isolated DNA under-
went bisulfite conversion using the EZ DNA Methylation
Kit (Zymo Research, Irvine, CA) according to manufac-
turer’s recommendation. DNA was stored at -20°C until use.
Bisulfite PCR and 454 sequencing
Primers for bisulfite-converted DNA were designed for
each pseudogene and the LIN28 gene (Table 1). Primers
covered CpG sites within and immediately surrounding
the protein-coding sequence of LIN28. As the four exam-
ined pseudogenes maintain high sequence identity to the
LIN28 gene and one another, primers were designed spe-
cific to each pseudogene to ensure only amplification of
the target pseudogene. Bisulfite-converted DNA was used
as a template for 25 μl PCR reactions using 1 to 3 μl
DNA. Reactions were carried out using the Mastercycler
thermal cycler (Eppendorf, New York, NY). Primer con-
centrations were 0.6 μM for all reactions. All reactions
were carried out using the following cycling parameters:
30 cycles of 94°C for 1 min, annealing temperature ran-
ging from 54 to 59°C for 1 min, and 72°C for 1 min for
30 cycles. A second PCR was performed using primers in-
cluding the original primer sequence with the addition of
the 454 adapter sequence, key sequence, and molecular
identification tags (designated as N) to differentiate indi-
vidual tissue samples (adapter A CGTATCGCCTCCCT
CGCGCCATCAGNNNNNNNNNN attached to the for-
ward primer and adapter B CTATGCGCCTTGCCAGCC
CGCTCAGNNNNNNNNNN attached to the reverse pri-
mer). The following cycling parameters were used: 94°C
for 30 sec, annealing temperature ranging from 55 to 60°C
for 30 sec, and 72°C for 30 sec for 15 cycles. The second
reaction used 1 μl of PCR product from the first PCR and
0.3 μM primer. All PCR samples used GoTaq Green Mas-
ter Mix (Promega, Madison, WI). All PCR reactions were
carried out on a Mastercycler thermal cycler (Eppendorf).








Reverse TTACCAAAAACCACAAACTTCACTT(Beckman Coulture, Brea, CA) and quantified using Pico-
Green (Life Technologies). PCR product was sequenced
using the 454 GD FLX Titanium DNA sequencer (Roche,
Indianapolis, IN). Amplicon libraries were subjected to
emulsion PCR to generate DNA-coated beads, loaded
onto a PicoTiterPlate, and sequenced with a FLX Titan-
ium DNA sequencing Kit according to the manufacturer’s
protocol.End-point RT-PCR
End-point RT-PCR reactions targeting bovine cDNA
were carried out using the Mastercycler thermal cycler
(Eppendorf). GoTaq Green Master Mix (Promega) was
used on all reactions with primer concentrations of
0.6 μM using the following cycling parameters: 40 cycles
of 94°C 15 sec, annealing temperature ranging from 58
to 60°C for 15 sec, and 72°C for 30 sec for 35 cycles. Fol-
lowing cycling, samples were electrophoresed on a 1%
agarose gel and imaged. Primers for end-point RT-PCR
are shown in Table 2.Sequence analysis
Sequencing data was analyzed to generate the frequency
of methylation using BISMA analysis software [46]. Any
sequence with a conversion rate less than 98% was ex-
cluded from sequence analysis. The average conversion
rate of all sequences was 99.2%. Data are presented as the
frequency of methylation on a per CpG site basis (number
of transcripts with methylated CpG site ÷ total number of
transcripts sequenced × 100). In order to account for the
potential of a C-to-T transition causing misinterpretation
of our results, known C/T SNPs were identified in the Sin-
gle Nucleotide Polymorphism database (http://www.ncbi.
nlm.nih.gov/snp). The database identified two CpG sites
that exist as either a cytosine or thymine in normal popu-
lations. CpG site 23 (rs43296056) in LIN28P-Ch:7 and
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from all methylation analysis.
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